Skip to main content

Month: April 2026

Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial

Vancouver, Canada, April 15, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that its independent Data and Safety Monitoring Board (“DSMB”) has completed its review and issued a positive recommendation to continue the ongoing FDA-approved Phase I/IIa clinical trial of CMND-100 for the treatment of Alcohol Use Disorder (“AUD”). The positive DSMB recommendation follows the successful completion of the third cohort and is based on encouraging top-line safety data demonstrating that CMND-100 was well tolerated with no serious adverse events reported. These...

Continue reading

TMGI Announces Completion of the Apache Creek Golf Club Acquisition, Expands Platform for Scalable Golf Operations and Tee-Time Technology Monetization

SCOTTSDALE, Ariz., April 15, 2026 (GLOBE NEWSWIRE) — Transglobal Management Group, Inc. (“TMGI” or the “Company”) (OTCID: TMGI) today announced the completion of the acquisition of the Apache Creek Golf Club, an 18-hole, par-71 public championship course located in Apache Junction, Arizona. Apache Creek generated approximately $2.7 million in revenue in 2025, with net profit exceeding $400,000, and is expected to grow in 2026. Beyond its financial profile, the asset provides TMGI with a live operating environment to deploy, test, and scale its proprietary technology platform across real-world operations. The acquisition of Apache Creek marks a foundational step in executing this strategy, as further outlined in the Company’s Form 10-Q filed April 13, 2026. Under the terms of the transaction, TMGI has completed the acquisition of...

Continue reading

Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression

Updated Safety, Efficacy, and Clinical Data Supports Teverelix as Potentially the First Long-Acting Injectable GnRH Antagonist Across Multiple Indications in Women’s Health PHILADELPHIA, April 15, 2026 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today announced it will present new Phase 1 clinical data on Teverelix, its investigational long-acting gonadotropin-releasing hormone (GnRH) antagonist, at the American Association of Clinical Endocrinology Annual Meeting 2026 (AACE 2026) on April 22-24th in Las Vegas, Nevada. Teverelix is being developed for hormone-driven conditions, with potential applications in women’s health,...

Continue reading

Orion Reiterates Expectations for Increased Growth and Profitability in FY 2026 and FY 2027; Strong Profitable Growth Drive Highlights Sally Washlow’s First Year as CEO

MANITOWOC, Wis., April 15, 2026 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today reiterated its preliminary expectations for increased revenue growth and profitability for its Fiscal Year 2026, which ended March 31, as well as its Fiscal 2027. Orion noted today’s one-year anniversary of the arrival of Sally Washlow as Chief Executive Officer in the reiteration of its publicly released expectations of January 20, when the Company announced an increase in its FY 2026 revenue outlook to a range of between $84 million and $86 million — up from its previous outlook of approximately $84 million. The Company said that it also expected to achieve positive adjusted EBITDA for the full...

Continue reading

GXO and Electro Dépôt Extend Strategic Logistics Partnership in France

Expanded footprint and advanced automation to support Electro Dépôt’s growth in France PARIS, France, April 15, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced the renewal and expansion of its long-standing partnership with Electro Dépôt, a leading European retailer specializing in home appliances and consumer electronics. Under the renewed agreement, GXO will continue to support Electro Dépôt’s growth strategy in France through an expanded logistics footprint, combining the extension of the existing Fos-sur-Mer site with the launch of a new distribution facility in Port-Saint-Louis-du-Rhône, dedicated to small domestic appliances. “This partnership extension with Electro Dépôt illustrates GXO’s ability to act as a long-term strategic partner for...

Continue reading

OTC Markets Group Welcomes EnSilica PLC to OTCQX

NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced EnSilica PLC (AIM: ENSI; OTCQX: ENSIF), a leading fabless, micro-chipmaker with a growing portfolio of reusable IP, serving the Space & Comms, Industrial, Automotive and Healthcare markets, has qualified to trade on the OTCQX® Best Market. EnSilica PLC begins trading today on OTCQX under the symbol “ENSIF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Trading on the OTCQX Market offers companies efficient, cost-effective access to the U.S. capital markets. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their...

Continue reading

Stereotaxis Announces Definitive Agreement to Acquire Robocath

ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has entered into a definitive agreement to acquire Robocath, a venture-backed innovator of robotic technologies for interventional cardiology and neurointerventions. This acquisition significantly strengthens Stereotaxis’ position as a leading platform for the full spectrum of endovascular procedures, combining complementary technologies to deliver next-generation fully-integrated robotic solutions for electrophysiology, interventional cardiology and neurointerventions. “Robocath represents a highly strategic addition to Stereotaxis, amplifying and accelerating our strategy as the leading robotic platform for the broad spectrum...

Continue reading

Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy

MELBOURNE, Australia and SAN FRANCISCO, April 15, 2026 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that it will host a virtual key opinion leader (KOL) event featuring Roy Freeman, MD (Harvard Medical School, Beth Israel Deaconess Medical Center) and Daniel Claassen, MD, MS (Vanderbilt University Medical Center), alongside David Stamler, MD, (CEO, Alterity Therapeutics), to discuss the significant unmet need and current treatment landscape in Multiple System Atrophy (MSA), a rare, rapidly progressive neurodegenerative disease with no approved treatment. Event Highlights to Include:ATH434 Overview: Alterity’s lead candidate and a potential first-in-class,...

Continue reading

Flagship Communities Real Estate Investment Trust Announces April 2026 Cash Distribution

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, April 15, 2026 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (“Flagship” or the “REIT”) (TSX:MHC.U) (TSX:MHC.UN) today announced a cash distribution of US$0.0545 per REIT unit for the month of April 2026, representing US$0.654 per REIT unit on an annualized basis. Payments will be made on or about May 15, 2026, to unitholders of record as of the close of business on April 30, 2026. Distributions paid to Canadian unitholders (and other non-U.S. unitholders) generally will be subject to U.S. withholding tax. Unitholders should consult their own tax advisors for advice with respect to the tax consequences of receiving a distribution from the REIT in their own circumstance. About Flagship Communities Real Estate Investment...

Continue reading

Bowman Awarded $4.9 Million Contract to Lead Construction Engineering & Inspection for Major Wastewater Treatment Expansion

RESTON, Va., April 15, 2026 (GLOBE NEWSWIRE) — Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, has been awarded a $4.9 million contract by Collier County, Florida to lead construction engineering and inspection (CEI) for the expansion of the Golden Gate Wastewater Treatment Plant. The assignment spans approximately 40 months of construction, providing multi-year revenue visibility. The project supports a broader $172 million infrastructure investment that will increase the plant’s capacity from 1.5 million gallons per day to 5.0 million gallons per day to support continued population growth in the region. Bowman’s relationship with Collier County spans nearly 30 years and includes hundreds of completed projects, many centered on advancing water and wastewater infrastructure....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.